Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients

Kana Toyama, Atsushi Yonezawa, Masahiro Tsuda, Satohiro Masuda, Ikuko Yano, Tomohiro Terada, Riyo Osawa, Toshiya Katsura, Masaya Hosokawa, Shimpei Fujimoto, Nobuya Inagaki, Ken Ichi Inui

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Multidrug and toxin extrusions (MATE1/SLC47A1 and MATE2-K/SLC47A2) play important roles in the renal excretion of metformin. We have previously identified the nonsynonymous MATE variants with functional defects at low allelic frequencies. The purpose of this study was to evaluate the effects of heterozygous MATE variants on the disposition of metformin in mice and humans. Pharmacokinetic parameters of metformin in Mate1(±) heterozygous mice were comparable with those in Mate1(+/+) wild-type mice. Among 48 Japanese diabetic patients, seven patients carried heterozygous MATE variant and no patient carried homozygous MATE variant. There was no significant difference in oral clearance of metformin with or without heterozygous MATE variants. In addition, creatinine clearance, but not heterozygous MATE variants, significantly improved the model fit of metformin clearance by statistical analysis using the nonlinear mixed-effects modeling program. In conclusion, heterozygous MATE variants could not influence the disposition of metformin in diabetic patients.

Original languageEnglish
Pages (from-to)135-138
Number of pages4
JournalPharmacogenetics and Genomics
Volume20
Issue number2
DOIs
Publication statusPublished - Feb 1 2010

Fingerprint

Metformin
Creatinine
Pharmacokinetics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients. / Toyama, Kana; Yonezawa, Atsushi; Tsuda, Masahiro; Masuda, Satohiro; Yano, Ikuko; Terada, Tomohiro; Osawa, Riyo; Katsura, Toshiya; Hosokawa, Masaya; Fujimoto, Shimpei; Inagaki, Nobuya; Inui, Ken Ichi.

In: Pharmacogenetics and Genomics, Vol. 20, No. 2, 01.02.2010, p. 135-138.

Research output: Contribution to journalArticle

Toyama, K, Yonezawa, A, Tsuda, M, Masuda, S, Yano, I, Terada, T, Osawa, R, Katsura, T, Hosokawa, M, Fujimoto, S, Inagaki, N & Inui, KI 2010, 'Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients', Pharmacogenetics and Genomics, vol. 20, no. 2, pp. 135-138. https://doi.org/10.1097/FPC.0b013e328335639f
Toyama, Kana ; Yonezawa, Atsushi ; Tsuda, Masahiro ; Masuda, Satohiro ; Yano, Ikuko ; Terada, Tomohiro ; Osawa, Riyo ; Katsura, Toshiya ; Hosokawa, Masaya ; Fujimoto, Shimpei ; Inagaki, Nobuya ; Inui, Ken Ichi. / Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients. In: Pharmacogenetics and Genomics. 2010 ; Vol. 20, No. 2. pp. 135-138.
@article{3507510e3a69400f960a468ca166070a,
title = "Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients",
abstract = "Multidrug and toxin extrusions (MATE1/SLC47A1 and MATE2-K/SLC47A2) play important roles in the renal excretion of metformin. We have previously identified the nonsynonymous MATE variants with functional defects at low allelic frequencies. The purpose of this study was to evaluate the effects of heterozygous MATE variants on the disposition of metformin in mice and humans. Pharmacokinetic parameters of metformin in Mate1(±) heterozygous mice were comparable with those in Mate1(+/+) wild-type mice. Among 48 Japanese diabetic patients, seven patients carried heterozygous MATE variant and no patient carried homozygous MATE variant. There was no significant difference in oral clearance of metformin with or without heterozygous MATE variants. In addition, creatinine clearance, but not heterozygous MATE variants, significantly improved the model fit of metformin clearance by statistical analysis using the nonlinear mixed-effects modeling program. In conclusion, heterozygous MATE variants could not influence the disposition of metformin in diabetic patients.",
author = "Kana Toyama and Atsushi Yonezawa and Masahiro Tsuda and Satohiro Masuda and Ikuko Yano and Tomohiro Terada and Riyo Osawa and Toshiya Katsura and Masaya Hosokawa and Shimpei Fujimoto and Nobuya Inagaki and Inui, {Ken Ichi}",
year = "2010",
month = "2",
day = "1",
doi = "10.1097/FPC.0b013e328335639f",
language = "English",
volume = "20",
pages = "135--138",
journal = "Pharmacogenetics and Genomics",
issn = "1744-6872",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients

AU - Toyama, Kana

AU - Yonezawa, Atsushi

AU - Tsuda, Masahiro

AU - Masuda, Satohiro

AU - Yano, Ikuko

AU - Terada, Tomohiro

AU - Osawa, Riyo

AU - Katsura, Toshiya

AU - Hosokawa, Masaya

AU - Fujimoto, Shimpei

AU - Inagaki, Nobuya

AU - Inui, Ken Ichi

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Multidrug and toxin extrusions (MATE1/SLC47A1 and MATE2-K/SLC47A2) play important roles in the renal excretion of metformin. We have previously identified the nonsynonymous MATE variants with functional defects at low allelic frequencies. The purpose of this study was to evaluate the effects of heterozygous MATE variants on the disposition of metformin in mice and humans. Pharmacokinetic parameters of metformin in Mate1(±) heterozygous mice were comparable with those in Mate1(+/+) wild-type mice. Among 48 Japanese diabetic patients, seven patients carried heterozygous MATE variant and no patient carried homozygous MATE variant. There was no significant difference in oral clearance of metformin with or without heterozygous MATE variants. In addition, creatinine clearance, but not heterozygous MATE variants, significantly improved the model fit of metformin clearance by statistical analysis using the nonlinear mixed-effects modeling program. In conclusion, heterozygous MATE variants could not influence the disposition of metformin in diabetic patients.

AB - Multidrug and toxin extrusions (MATE1/SLC47A1 and MATE2-K/SLC47A2) play important roles in the renal excretion of metformin. We have previously identified the nonsynonymous MATE variants with functional defects at low allelic frequencies. The purpose of this study was to evaluate the effects of heterozygous MATE variants on the disposition of metformin in mice and humans. Pharmacokinetic parameters of metformin in Mate1(±) heterozygous mice were comparable with those in Mate1(+/+) wild-type mice. Among 48 Japanese diabetic patients, seven patients carried heterozygous MATE variant and no patient carried homozygous MATE variant. There was no significant difference in oral clearance of metformin with or without heterozygous MATE variants. In addition, creatinine clearance, but not heterozygous MATE variants, significantly improved the model fit of metformin clearance by statistical analysis using the nonlinear mixed-effects modeling program. In conclusion, heterozygous MATE variants could not influence the disposition of metformin in diabetic patients.

UR - http://www.scopus.com/inward/record.url?scp=75649118895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75649118895&partnerID=8YFLogxK

U2 - 10.1097/FPC.0b013e328335639f

DO - 10.1097/FPC.0b013e328335639f

M3 - Article

C2 - 20016398

AN - SCOPUS:75649118895

VL - 20

SP - 135

EP - 138

JO - Pharmacogenetics and Genomics

JF - Pharmacogenetics and Genomics

SN - 1744-6872

IS - 2

ER -